These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8113208)

  • 1. Management of hematological disorders and cancer.
    McLeod BC; Strauss RG; Ciavarella D; Gilcher RO; Kasprisin DO; Kiprov DD; Klein HG
    J Clin Apher; 1993; 8(4):211-30. PubMed ID: 8113208
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic apheresis in hematological and oncological diseases.
    Grima KM
    J Clin Apher; 2000; 15(1-2):28-52. PubMed ID: 10767050
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic apheresis in the United States: current indications and directions.
    Smith JW
    Ther Apher; 1999 Feb; 3(1):1-3. PubMed ID: 10079798
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic haemapheresis.
    Sibinga CT
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):79-83. PubMed ID: 3242963
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of autoimmune disorders.
    Kiprov DD; Strauss RG; Ciavarella D; Gilcher RO; Kasprisin DO; Klein HG; McLeod BC
    J Clin Apher; 1993; 8(4):195-210. PubMed ID: 8113207
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction to the third special issue: clinical applications of therapeutic apheresis.
    McLeod BC
    J Clin Apher; 2000; 15(1-2):1-5. PubMed ID: 10767047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma exchange therapy in hematology].
    Höcker P; Pittermann E
    Wien Klin Wochenschr; 1985 Feb; 97(3):115-22. PubMed ID: 4039090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin.
    Bambauer R; Latza R; Burgard D; Schiel R
    Ther Apher Dial; 2016 Oct; 20(5):433-452. PubMed ID: 27633388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extensive plasma exchange in ABO-incompatible bone marrow transplantation ].
    Osterwalder B; Gratwohl A; Bannert P; Müller M; Nissen C; Burri HP; Speck B
    Ther Umsch; 1982 Jul; 39(7):519-23. PubMed ID: 6750836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic apheresis in hematologic disorders; its indication and evaluation].
    Amemiya Y; Baba M
    Nihon Naika Gakkai Zasshi; 1986 Mar; 75(3):352-6. PubMed ID: 3528353
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemapheresis and hemorheology.
    Avanzi G; Mannini L
    Transfus Sci; 1990; 11(3-4):279-80. PubMed ID: 10149529
    [No Abstract]   [Full Text] [Related]  

  • 13. Indications of plasma exchanges in 2000.
    Guillevin L; Bussel A
    Ann Med Interne (Paris); 2000 Mar; 151(2):123-35. PubMed ID: 10855365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible living donor liver transplantation: new insights into clinical relevance.
    Kawagishi N; Satomi S
    Transplantation; 2008 Jun; 85(11):1523-5. PubMed ID: 18551048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The therapy of hematologic-oncologic emergencies].
    Wiebecke D
    Klin Anasthesiol Intensivther; 1993; 45():206-10. PubMed ID: 8271766
    [No Abstract]   [Full Text] [Related]  

  • 16. This last edition of Transfusion and Apheresis Science of 2010, is substantial, with 23 full-length articles.
    Rock G
    Transfus Apher Sci; 2010 Dec; 43(3):249-250. PubMed ID: 21075687
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma-exchange and in vivo immunoabsorption of isohemagglutinins in bone marrow transplantation across major ABO barrier.
    Iacone A; D'Arcangelo L; Di Bartolomeo P; Di Girolamo G; Dragani A; Torlontano G
    Haematologica; 1982; 67(6):874-84. PubMed ID: 6819193
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes after major or bidirectional ABO-mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor-type secretor plasma with or without plasma exchange.
    Curley C; Pillai E; Mudie K; Western R; Hutchins C; Durrant S; Kennedy GA
    Transfusion; 2012 Feb; 52(2):291-7. PubMed ID: 21848968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous gammaglobulin therapy: current role in bone marrow transplant, malignancy, and immune hematologic disorders.
    Sacher RA
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):1-5. PubMed ID: 1509288
    [No Abstract]   [Full Text] [Related]  

  • 20. Our first experiences in applying an original method for removal of ABO-isoagglutinins in ABO-incompatible kidney recipients.
    Ignjatović L; Kovacević Z; Jovanović D; Vavić N; Paunić Z; Radojević M; Rabrenović V; Obrencević K; Mijusković M; Draskovic-Pavlović B; Ostojić G; Balint B; Bokonjić D
    Vojnosanit Pregl; 2009 Feb; 66(2):117-22. PubMed ID: 19281122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.